Publications by authors named "Richard Lottenberg"

Claim this Profile
D
Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice.
Adam Cuker, Robert Kunkle, Rachel S Bercovitz, Michael Byrne, Benjamin Djulbegovic, Richard Lottenberg

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Jane S Hankins, Donald Brambilla, Michael B Potter, Abdullah Kutlar, Robert Gibson, Richard Lottenberg

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASH Clinical Practice Guidelines: strategies to stay up-to-date.
Matthew C Cheung, Rob Kunkle, Rob Plovnick, Richard Lottenberg, Suely M Rezende

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee.
Michael Byrne, Ryan Mattison, Rachel Bercovitz, Richard Lottenberg, Suely M Rezende

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease.
Andrea E Lamont, Lewis L Hsu, Sara Jacobs, Robert Gibson, Marsha Treadwell, Richard Lottenberg

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
Wally R Smith, Donna K McClish, Richard Lottenberg, India Y Sisler, Daniel Sop

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease.
Matthew Lyon, Lashon Sturgis, Richard Lottenberg, Marin E Gibson, Jonathan Eck

Ann Emerg Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.
Jane S Hankins, Nirmish Shah, Lisa DiMartino, Donald Brambilla, Maria E Fernandez, Richard Lottenberg

JMIR Res Protoc· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A user guide to the American Society of Hematology clinical practice guidelines.
Ariel Izcovich, Adam Cuker, Robert Kunkle, Ignacio Neumann, Julie Panepinto, Richard Lottenberg

Blood Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence gaps in the management of sickle cell disease: A summary of needed research.
William J Savage, George R Buchanan, Barbara P Yawn, Araba N Afenyi-Annan, Samir K Ballas, Richard Lottenberg

Am J Hematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to the diagnosis and treatment of acute subarachnoid hemorrhage in a patient with sickle cell disease.
Matthew Lyon, Justin Jeter, Richard Lottenberg

Am J Emerg Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the use of hydroxyurea therapy in sickle cell disease.
Trisha E Wong, Amanda M Brandow, Wendy Lim, Richard Lottenberg

Blood· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferior vena cava filters in trauma patients: a national practice patterns survey of U.S. Trauma centers.
Anita Rajasekhar, Hany Elmariah, Lawrence Lottenberg, Rebecca Beyth, Richard Lottenberg

Am Surg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Barbara P Yawn, George R Buchanan, Araba N Afenyi-Annan, Samir K Ballas, Kathryn L Hassell, Richard Lottenberg

JAMA· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption.
Kathryn L Hassell, Araba Afenyi-Annan, Samir K Ballas, George R Buchanan, James R Eckman, Richard Lottenberg

Am J Respir Crit Care Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
Martina Murphy, Julia Close, Richard Lottenberg, Anita Rajasekhar

Am J Med Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery.
Se-woon Choe, David S Terman, Angela E Rivers, Jose Rivera, Richard Lottenberg

J Control Release· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.
Levette N Dunbar, Larae Coleman Brown, Donna R Rivera, Abraham G Hartzema, Richard Lottenberg

ISRN Hematol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
Jane Ritho, Huazhi Liu, Abraham G Hartzema, Richard Lottenberg

Am J Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study on the randomization of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patients.
Anita Rajasekhar, Lawrence Lottenberg, Richard Lottenberg, Robert J Feezor, Scott B Armen

J Trauma· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the meta-analysis of observational studies in epidemiology (MOOSE) guidelines.
Anita Rajasekhar, Richard Lottenberg, Lawrence Lottenberg, Huazhi Liu, Darwin Ang

J Thromb Thrombolysis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio.
Anita Rajasekhar, Rob Gowing, Ryan Zarychanski, Donald M Arnold, Wendy Lim, Richard Lottenberg

Crit Care Med· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial adaptation and infection.
Michael D Boyle, Richard Lottenberg

Inflamm Allergy Drug Targets· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic storm in Kimura disease.
Hong Liu, Samer Z Al-Quran, Richard Lottenberg

J Thromb Thrombolysis· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmalignant blood disorders: time to establish a public health agenda.
Richard Lottenberg

Am J Prev Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis